Submitted by U.Porto Inovação on 12/01/26
BBIT20 is the first known suppressor of homologous recombination capable of inhibiting the BRCA1/BARD1 interaction. It represents a significant advancement in the treatment of aggressive, hard-to-treat cancers.
Imagem:
Ano:
2020-2021
Entidade:
Faculty of Pharmacy, University of Porto (FFUP)
Categoria:
